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Objective:Mental illness often interferes with daily functioning and an individual’s pattern
of psychiatric signs and symptoms may predict risk of future disability. Understanding the
linkage between psychiatric symptoms and impaired functioning is critical for accurate
rehabilitation planning and legal assessment. Here, we investigated the stability of
functional impairment measures over 18 months and their association with psychiatric
symptoms. Moreover, we developed a clinical self-report measure that allows estimation
of functional impairment levels over 18 month observation periods.
Methods: Consecutively treated outpatients and daycare patients (N = 155) from
several psychiatric units in Switzerland completed the Dissociative Experiences Scale,
Somatoform Dissociation Questionnaire, Multidimensional Inventory for Dissociation,
Beck Depression Inventory, Brief Symptom Inventory, and WHO Disability Assessment
Schedule at baseline, 6, 12, and 18 month follow-up examinations. The association
between symptoms functional impairment over time was investigated using longitudinal
linear mixed models. Penalized regression was used to identify questionnaire items that
best predicted functional impairment.
Results: We found high stability in the extent of functional impairment over 18 months.
Fear of negative evaluation, fatigue, concentration problems, negative alterations in
mood, and dissociative symptoms showed the strongest association with functional
impairment measures. The empirically derived scale for functional impairment prediction
explained between 0.62 and 0.77 of the variance in disability across various life domains.
Conclusion: Given the capability for somatic and mental symptoms associated with
social anxiety, depression, and dissociation to predict future disability, these symptoms
have strong potential for guiding rehabilitation planning and prognostic evaluation in
insurancemedicine. The Functional Impairment Prediction Scale may serve as a valuable,
empirical-based extension in legal assessments of how work capacity is affected by
psychological factors.
Keywords: disability, functional impairment, insurance medicine, legal assessment, daily functioning,
occupational health
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INTRODUCTION
Mental illness often interferes with daily functioning and work
ability. Worldwide, psychiatric disability accounts for the highest
proportion of disability among all diseases (1). In Switzerland,
43% of disability payments newly granted in the last decade
are associated with mental disorders (2). Data in other West
European countries, America and Australia are similar, and in
most countries an increasing percentage of disability payments
are granted due to mental disorders. A study conducted by
the Organization for Economic Cooperation and Development
(OECD) in West European countries, America and Australia
reported an overall increase of disability payments due to
mental disorders from the mid-1990s through 2009. In 2009,
the proportion of disability payments due to mental disorders
were between 24.9% (Norway) and 44.2% (Denmark). In a
majority of countries, this rate increased by more than a factor
of two during the observation period. Only the Netherlands
and the United States showed slightly decreasing rates of 0.89
and 0.95, respectively (3). Similar results has been reported by
the Mental Health Economics European Network (MHEEN) (4)
and in some country-specific studies. In the UK, for instance,
government data from 1995 to 2014 showed a decrease of
overall disability payments by 6.4%, but an increase in payments
due to mental disorders from 21.4 to 45.4% (5). A cohort
study conducted in the Netherlands between July 2010 and
June 2011 revealed that 33% of men and 35% of women who
received disability payments had a main diagnosis of a mental
disorder (6). In the US, the Annual Statistical Report on the
Social Security Disability Insurance of 2017 reported a rate
of 35% of mental disorders among all disabled beneficiaries
(7). The major challenges mental disorders represent for the
health and social security systems of both developed and
developing countries call for better insights into the mechanisms
causing disability.
Ample evidence supports an association between mental
disorders and functional impairment in various life domains.
In a German cohort study, the risk for permanent disability
was increased by a factor of 2.5 in individuals with depressive
disorders, and by a factor of 1.3 in individuals with anxiety
disorders (8). Among anxiety disorders, the highest correlations
have been observed between the severity of obsessive-compulsive
disorder and social anxiety disorder with levels of global disability
(9). A Chinese study among patients with remitted or partially
remitted major depression, residual symptoms of fatigue,
psychomotor changes, sleep disturbances and weight/appetite
disturbances were related to functional impairment (10). In a
Spanish study of primary care patients, depressive symptoms
were related to impaired social life, family life and work,
anxiety was realted to impaired family life, and somatization
associated with impaired functioning at work. A study among
Canadian outpatients with obsessive-compulsive disorder found
that obsessions, checking behavior, and hoarding had the
greatest impact on daily functioning (11). Not surprisingly,
psychotic symptoms contribute to impairment in individuals
with schizophrenia (12, 13), with negative symptoms accounting
for up to 18% of the variance in functioning (9, 14).
Mental disorders are often heterogeneous in their
phenomenology. This complexity is reflected in the lists of
diagnostic criteria in the Diagnostic and Statistical Manual
of Mental Disorders (DSM), where some diagnoses are
characterized by a considerable number of signs and symptoms.
It is unlikely that all signs and symptoms respond equally
well to similar treatments or contribute equally to functional
impairment. For instance, the DSM-5 (15) lists 20 distinct signs
and symptoms for posttraumatic stress disorder (PTSD). Of
these, re-experiencing and avoidance symptoms usually improve
after successful exposure therapy (16), while irritability and sleep
disturbances may be more effectively treated pharmacologically
(17). Almost all previous studies have investigated disability at
the disorder level. Moreover, it is largely unknown which signs
and symptoms clustered within a diagnosis contribute to the
observed associations between mental disorders and functional
impairment. There aremultiple factors contributing to functional
impairment, including job characteristics, psychosocial factors
and functioning capacity (18). Knowing the functionally most
influential signs and symptoms, would allow tailoring treatment
options to optimize chances for vocational rehabilitation.
Detailed knowledge concerning the influence of psychiatric signs
and symptoms on work disability is also needed to achieve the
most accurate assessment of individual working capability.
In psychiatric legal assessments, it is the evidence for
psychopathology, not diagnosis, that provides the basis for
disability payment claims (19). Basing decisions on evidence
of psychopathology seems reasonable, because there is vast
variability in working capacity among individuals with the same
psychiatric diagnosis. In this context, medical experts must
provide plausible and evidence-based explanations concerning
which signs and symptoms a claimant suffers could interfere with
work performance. Moreover, diagnostic criteria in classification
systems such as the DSM-5 are subject to change, while sign and
symptom constructs are usually better established and stable over
time. Hence, evidence regarding the strength of an association
between specific signs and symptoms and functional impairment
is more applicable in legal assessments than is evidence relating
to specific mental disorders.
The primary objective of this prospective study in outpatient
and daycare patients with a broad range of psychiatric disorders
was to investigate the association of functional impairment with
psychiatric signs and symptoms.
MATERIALS AND METHODS
Procedure
Participants between 18 and 65 years with sufficient fluency
in the German language, who were in treatment for three
or more sessions during 1/2009 to 12/2010, were eligible for
study participation. Participants were recruited from two public
psychiatric outpatient units, one private practice, and two
psychiatric daycare units, all located in the counties of St. Gallen
or Zurich in Switzerland. Exclusion criteria comprised acute
psychosis, acute suicidal ideation, substance abuse with acute
intoxication or withdrawal, mental retardation, and psychiatric
Frontiers in Psychiatry | www.frontiersin.org 2 February 2019 | Volume 10 | Article 37
Tanner et al. Psychiatric Symptom Profiles Predict Functioning
disorders due to an underlying medical condition. The study
protocol was approved by the institutional review board of
the county of St. Gallen, Switzerland. All participants provided
written informed consent according to the Declaration of
Helsinki. Study participation was compensated.
Measurements
Axis I and Axis II diagnoses were ascertained at baseline using
the Structured Clinical Interview for DSM-IV Disorders Axis I
(SCID-I) (20) and Axis II (SCID-II) (21). Dissociative disorders
were ascertained using the Structured Clinical Interview
for Dissociative Disorders (SCID-D-R) (22, 23). Inter-rater
reliability of SCID-I and SCID-II is fair-to-excellent (24). The
SCID-D-R is performed as a semi-structured interview. The
categorical diagnosis of a Dissociative Disorder is based on the
dimensional assessment of five dissociative symptoms “amnesia.”
“depersonalization,” “derealization,” “identity confusion,” and
“identity alteration” on a 4-point-Likert scale (1 = none, 2 =
mild, 3 = moderate, 4 = severe). The interviewer rates the
severity of each of the five dissociative symptoms according to
specific behaviors and experiences reported by the patient as well
as the observation of dissociative symptoms during the interview.
The reliability and validity of SCID-D-R is good-to-excellent
(25, 26). The assessments were performed by trained interviewers
(with B.Sc. or M.Sc. degrees).
Symptom severity was measured using the German versions
of the Dissociative Experiences Scale (DES), Somatoform
Dissociation Questionnaire (SDQ-20), Multidimensional
Inventory of Dissociation (MID), Beck Depression Inventory
(BDI), and Brief Symptoms Inventory (BSI). The DES and
SDQ-20 were collected at baseline only. The scales were
chosen to collect a broad range of psychiatric symptoms
including dissociative symptoms that were a focus of the main
study (27–29).
The DES is one of the most commonly used questionnaires
measuring psychological manifestations of dissociation in typical
and clinical populations (30). Ratings for the 28 items of the
DES are based on an 11-point scale with increments of 10 points
ranging from 0 (“never”) to 100 (“always”), with higher scores
representing more frequent dissociative symptoms. Although the
authors of the DES derived three factors, including absorption,
amnesia, and depersonalization/derealization, results from later
studies suggested a single factor only (31, 32). The DES has
sound psychometric properties (30, 33–35). The psychometric
properties of the German adaptation of the DES (Cronbach’s
alpha = 0.91; test–retest reliability Pearson r = 0.86; good
differentiation of psychiatric patients from healthy participants,
and psychiatric patients with a DD from psychiatric patients
without a DD and healthy participants) are comparable to the
original version (36, 37).
The SDQ-20 (38) is a 20-item rating scale that measures
somatoform manifestations of dissociation such as disruptions
in sensation, movement and other bodily functions. The rating
of the 20 items of the SDQ-20 is based on a 5-point scale
ranging from 1 to 5, yielding a minimum score of 20 and a
maximum score of 100, with higher scores representing greater
levels of somatoform dissociation. Factor analyses have suggested
unidimensionality of the SDQ-20 (39). The psychometric
properties of the SDQ-20 are good (38–40). The German adapted
SDQ-20 shows excellent psychometric properties (Cronbach’s
alpha = 0.91; test–retest reliability Pearson r = 0.89; good
differentiation between patients with vs. without DD) and cross-
cultural validity (40).
The MID (41–43) is a comprehensive scale with 218 items
(168 dissociation items, 50 validity items) for the measurement
of pathological dissociation. It assesses 6 general dissociative
symptoms (i.e., “memory problems,” “depersonalization,”
“derealization,” “flashbacks,” “somatic symptoms,” “trance”), 11
consciously experienced intrusions from a dissociated self-state,
and 6 fully-dissociated activities of another self-state. The items
are rated on an 11-point scale that ranges from 0 (“never”) to 10
(“always”). The scale provides a summary score between 0 and
100 by calculating the mean score of the 168 dissociation items,
multiplied by 10. The MID has demonstrated good reliability
and validity (41). Preliminary data suggests sound psychometric
properties of the German version of the MID (Cronbach’s alphas
between 0.69 and 0.94; good differentiation between patients
with vs. without a Dissociative Disorder) (44).
The BDI is an internationally used questionnaire with 21 items
measuring depressive symptoms. The German version of the BDI
shows good reliability (45). The items are rated on a 4-point
scale ranging from 0 to 3, yielding a minimum sum score of 0
and a maximum sum score of 63 with higher scores representing
greater levels of depression.
The BSI is a short version of the Symptom Checklist of
Derogatis (SCL-90-R). The questionnaire is internationally used
and contains 53 items capturing subjective impairment due
to physical and mental symptoms. It allows measurement
of the dimensions “somatization,” “obsession-compulsion,”
“interpersonal sensitivity,” “depression,” “anxiety,” “hostility,”
“phobic anxiety,” “paranoid ideation,” and “psychoticism.” The
53 items are based on a 5-point scale ranging from 0 to 4. In this
study, the global severity index score was used, consisting of the
mean of the 53 items. The reliability of the German version of BSI
is fair, with restricted generalizability because of a predominance
of anxiety patients in the reference sample (46).
Functional impairment was assessed using the World Health
Organization Disability Assessment Schedule II (WHODAS II)
(47), a standardized method for measuring disability levels based
on the based on the International Classification of Functioning,
Disability and Health (ICF) (48). The WHODAS II has replaced
the Global Assessment of Functioning Scale (GAF) (49) for
describing disability associated with symptoms and signs in
DSM-5. At baseline, the interviewer administered version of the
WHODAS II was used; at follow-ups, the self-rating version
was used. Both versions used contain 36 questions covering six
domains of assessment. These are based on the International
Classification of Functioning, Disability andHealth (48), a system
that classifies impairments in body functions and structure;
activity limitations; participation restrictions; and environmental
factors caused by mental or physical illness. The items are
based on a 5-point rating scale with the participant rating
the level of difficulty experienced as none, mild, moderate,
severe, or extreme, with higher scores reflecting higher functional
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impairment. According to the WHODAS II manual, the
participant’s ratings are recorded without interpretation by the
interviewers. TheWHODAS II provides a total score and domain
scores for the life domains “understanding and communicating”
(cognition); “getting around” (mobility); “self-care” (attending
to one’s hygiene, dressing, eating, and staying alone); “getting
along with people” (interpersonal interactions); “life activities”
(domestic responsibilities, work); and “participation in society”
(joining in community activities). The psychometric properties of
WHODAS II are sound, with high interrater reliability (50–52).
Data Analysis
All item scores of symptom and functional impairment
measures were centered and scaled. The items of each symptom
questionnaire were assigned to corresponding DSM-5 (15)
symptoms. Assignment was done by the first author (JT) and
reviewed by the last author (CM-P). Chi-squared tests were
used to compare categorical data, t-tests were used to compare
dimensional data between recruited participants and decliners,
and study drop-outs and completers.
To investigate the temporal stability of functional impairment,
we conducted a separate mixed-effects linear model (53) on
WHODAS total and dimension scores for each diagnostic
category. Time (baseline, 6, 12, and 18months), age, and sex were
treated as fixed effects and subject as a random effect. Similar
models on symptom scores (represented by the average score
across the items that were assigned to DSM-5 symptoms within
a diagnostic category) were conducted to investigate temporal
stability of symptoms for each diagnostic category. Cook’s
distance scores were calculated for each model for estimating the
influence of individual observations (54). The cut-off for Cook’s
distance was automatically calculated using measures of internal
scaling. Because there were no significant interactions involving
time (data not presented), interaction terms were omitted in
the models.
To investigate the association between DSM-5 symptoms
and functional impairment, we conducted separate mixed-effects
linear models on WHODAS total and dimension scores for each
symptom. Symptom scores (represented by the mean score of the
items assigned to this DSM-5 symptom), time, age, and sex were
treated as fixed effects and participant as a random effect.
Age and sex were included in the mixed-effects linear
regression models to control for a potential confounding effect
of these subject characteristics on the results of the regression
models. We have conducted a separate model for each symptom
(instead of conducting one model that includes all symptoms as
predictors) for two reasons: (1) we aimed to investigate the “pure”
effect of each symptom on functional impairment, controlling
for other influences. Including all symptoms in one model might
have influenced the parameter estimates for symptoms that are
correlated with each other (e.g., depressed mood and diminished
interest); (2) a high number of predictors in one model might
result in instability of the resulting parameter estimates. A
larger sample size would have been needed to mitigate these
effects. Standardized parameter estimates (β) and 95% confidence
intervals (CI) were used to estimate effect sizes for the association
between symptom and functional impairment.
To develop a questionnaire that predicts functional
impairment, a separate penalized lasso regression model (55) was
conducted on WHODAS total and dimension baseline scores.
The items of the MID, DES, SDQ-20, BDI, and BSI were entered
as predictors. Items with an absolute standardized estimate
of greater or equal 0.5 were selected for the questionnaire.
Although a change of 0.5 may be below clinical relevance, such a
conservative cut-off was used to prevent excessing elimination of
items based on this relatively small sample. Explained variance
in predicting WHODAS total and dimension scores across
18 months by this set of items was calculated using separate
mixed-effects linear models with time, age, and sex treated as
additional fixed effects, and participant as a random effect.
Because the results for WHODAS dimension scores were
very similar (see Supplemental Material), only WHODAS total
scores are reported in the paper. A critical threshold of p = 0.05
(two-sided) was used; statistical analyses were performed using R
V.3.4.3 (56).
RESULTS
Participants
All 312 participants fulfilling study criteria were invited to
participate. Of these, 136 (43.6%) declined to participate,
yielding a pool of 176 recruited participants. There was no
statistically significant difference between recruited participants
and decliners regarding sex (p = 0.5), age (p = 0.05), and
nationality (p = 0.9), suggesting good representativeness of our
sample. Finally, data from 21 recruited participants (11.9% of
the 176) were excluded from the analysis due to incomplete
participation in the baseline assessment, diagnosis of a psychotic
disorder (acute or remitted) or doubtful validity of the results as
judged by the interviewer after discussion with the first author,
e.g., suspected dissimulation or difficulties in understanding the
questions. Participants with acute or stable psychotic disorder
have been excluded from the study due to concerns of invalid
self-reports at follow-up due to unrecognized psychotic relapse.
Self-reports were completed from home without any further in-
person evaluation. This procedure resulted in a final sample
size of 155 participants. Participants were assessed at baseline
(N = 155), after six (N = 117), 12 (N = 82), and 18 months
(N = 63). Thirty participants (19.4%) had at study entrance a
lifetime Axis I diagnosis, i.e., were in clinical remission; six of
them had a current Axis II diagnosis. Sociodemographic and
clinical characteristics at baseline and follow-up are presented in
Tables 1, 2, respectively. Drop-outs did not differ significantly
from study completers with respect to sociodemographic
characteristics, diagnoses, and symptom severity (p ≥ 0.05).
Temporal Stability of Functional
Impairment and Symptom Severity
Functional impairment was stable across 18 months for
participants within each diagnostic category (Figure 1), as
evidenced by non-significant effects of time on mean WHODAS
total scores (p ≥ 0.251; Table 3). There were also no significant
effects of time on any of the WHODAS dimension scores (p ≥
0.076; Supplementary Tables 1–6).
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TABLE 1 | Sociodemographic and clinical characteristics at baseline of outpatient
and daycare patients (N = 155).
N %
Female 105 67.7
Swiss nationality 110 71.0
PRIMARY SOURCE OF INCOME
Own earnings 38 24.5
Earnings of partner, parents, or relatives 19 12.3
Retirement payments 3 1.9
Disability payments due to a mental disorder 30 19.4
Disability payments due to a physical disorder 6 3.9
Public welfare 35 22.6
Unemployment benefits 10 6.5
Other, e.g. savings 14 9.0
DIAGNOSTIC CATEGORIESa
Affective disorders 78 50.3
Substance use disorders 16 10.4
Anxiety disorders 80 51.9
Somatoform disorders 15 9.7
Dissociative Disorders 30 19.4
Personality Disorders 68 44.2
Mean SD
Age (years) 35.8 11.8
Education (years) 12.4 3.3
Number of axis I diagnoses 1.7 1.4
DES 14.5 13.7
SDQ-20 29.7 9.9
aAccording to DSM-IV; DES, Dissociative Experiences Scale; SDQ-20, Somatoform
Dissociation Questionnaire.
Symptom severity related to affective disorders, anxiety
disorders, somatoform disorders, and dissociative disorders was
stable across 18 months (Figure 2). This was as evidenced by
non-significant effects of time on mean symptom scores within
each diagnostic category (p ≥ 0.210; Table 4).
Association Between Symptoms and
Functional Impairment
As seen in Figure 3 and Table 5, mean functional impairment
effect sizes across 18 months were highest for symptoms
related to social anxiety disorder, conversion disorder,
dissociative identity disorder, major depression, and
depersonalization/derealization disorder. Mean functional
impairment effect sizes were intermediate for symptoms
related to PTSD, specific phobia, generalized anxiety disorder,
agoraphobia, and panic disorder. Lowest effect sizes were found
for symptoms related to dissociative amnesia and obsessive-
compulsive disorder. Effect sizes and 95% CIs are also presented
in Supplementary Tables 7–13.
With very few exceptions, all symptoms had a statistically
significant effect on functioning. However, there was often high
variability in the strength of the association between the various
symptoms of a specific disorder and functional impairment.
In major depression, fatigue or loss of energy, thinking or
concentration problems, and depressed mood were significantly
higher than recurrent thoughts of death, suicidality, weight loss
or weight gain. Although statistically not significant, sleeping
problems seem to have a smaller effect on functioning than
diminished interest or pleasure, feelings of worthlessness, guilt,
and psychomotor agitation or retardation.
Among symptoms in posttraumatic stress disorder, dissociate
reactions (e.g., flashbacks), diminished interest or participation
in significant activities, and psychological distress at exposure
to traumatic cues, had the strongest effects on functioning. In
contrast, exaggerated startle responses and cognitive distortions
had small effect sizes.
In panic disorder, derealization or depersonalization and
breathing problems seem to have stronger effects on functioning
than other mental and physical manifestations of fear. The
observed differences may have occurred by chance, as indicated
by the overlapping confidence intervals.
Questionnaire Items That Predict
Functional Impairment
Of all 290 symptom items in the MID, DES, SDQ-20, BDI,
and BSI, 47 predicted functional impairment (Table 5). Among
the 47 items, 27 items referred to various type of dissociative
experiences, 11 items to depressive symptoms, and 9 items to
symptoms of anxiety. Explained variance (conditional R2) of this
final set of items was 0.77 for predicting WHODAS scores across
domains, 0.68 for “understanding and communicating,” 0.62 for
“getting around,” 0.64 for “self-care,” 0.74 for “getting along
with people,” 0.72 for “life activities” and 0.68 for “participation
in society”.
DISCUSSION
The main aim of this prospective study was to investigate
the temporal stability of functional impairments and their
association with psychiatric signs and symptoms. We found high
stability in the extent of functional impairment across 18 months.
Substantial relative differences were observed in the strength of
the association of DSM-5 signs and symptoms and functional
impairment measures both between and within disorders.
Core symptoms of social anxiety disorder, major depression,
conversion disorder and dissociative identity disorder had among
the strongest relative effects on functioning.
Average levels of functional impairment in our sample
remained stable across 18 months and diagnostic categories.
This was accompanied by stable average levels of symptoms
related to affective disorders, anxiety disorders, somatoform
disorder, and dissociative disorders. Although symptom levels
in major depression fluctuate over time, their course is often
chronic (57). The same is true for generalized anxiety disorders
(58) and PTSD (59). While some studies found that disability
varies directly with the levels of depressive symptoms (60),
others observed long disability even after remission of depressive
symptoms (61).
Our finding that fear of negative evaluations (a core
symptom in social anxiety disorder) has the highest adverse
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TABLE 2 | Symptom severity and functional impairment across 18 months of outpatient and daycare patients.
Baseline
(N = 155)
6 Months
(N = 117)
12 Months
(N = 82)
18 Months
(N = 63)
Mean SD Mean SD Mean SD Mean SD
MID 21.0 15.9 15.8 16.0 15.1 17.1 14.9 17.2
BDI 23.0 10.5 23.1 11.7 21.6 12.7 21.7 12.6
BSI 1.3 0.7 1.3 0.8 1.2 0.8 1.1 0.8
WHODAS II
Total 35.7 20.2 35.4 20.0 35.0 21.4 33.6 22.0
Understanding and Communication 31.7 22.0 33.0 21.3 32.1 23.2 31.7 22.8
Getting Around 24.2 24.6 23.5 23.6 24.2 23.6 20.8 21.9
Self-Care 17.9 20.0 17.2 20.3 20.2 22.6 18.9 21.1
Getting Along with People 40.2 30.6 46.1 29.5 46.0 30.7 43.9 31.1
Life Activities 43.3 32.6 41.7 30.3 40.9 30.4 40.4 33.4
Participation in Society 48.1 24.8 41.6 24.3 38.6 24.0 36.8 25.4
MID,Multidimensional Inventory of Dissociation; BDI, Beck Depression Inventory; BSI, Brief Symptom Inventory;WHODAS II, World Health Organization Disability Assessment Schedule II.
FIGURE 1 | Functional impairment across WHODAS II domains during 18 months in outpatients and day-care patients (N = 155) by DSM-IV diagnostic category. The
thick red line represents the mean functional impairment score and the associated ribbon the standard deviation. The colored thin lines represent functional
impairment scores of individual cases. Higher scores represent higher impairment across life domains.
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TABLE 3 | Results of linear mixed effect models on the 18-month course of functional impairment across WHODAS II domains of outpatient and daycare patients (N =
155).
Variable β 95% CI SE df t p
AFFECTIVE DISORDERS (Conditional R2 = 0.67, Cook’s distance = 15/78)
Intercept −0.14 −1.01, 0.74 0.45 79.21 −0.312 0.756
Time −0.04 −0.13, 0.04 0.04 81.57 −0.969 0.335
Age 0.00 −0.02, 0.02 0.01 76.59 0.073 0.942
Sex 0.29 −0.1, 0.68 0.20 74.41 1.462 0.148
SUBSTANCE DISORDERS (Conditional R2 = 0.87, Cook’s distance = 2/16)
Intercept −1.68 −3.59, 0.23 0.97 13.86 −1.728 0.106
Time 0.02 −0.17, 0.2 0.10 8.89 0.156 0.879
Age −0.00 −0.05, 0.04 0.02 13.12 −0.122 0.905
Sex 0.95 0.16, 1.74 0.40 13.10 2.364 0.034
ANXIETY DISORDERS (Conditional R2 = 0.80, Cook’s distance = 14/80)
Intercept −0.65 −1.66, 0.35 0.51 79.31 −1.276 0.206
Time −0.02 −0.09, 0.05 0.03 38.07 −0.628 0.534
Age −0.00 −0.02, 0.02 0.01 78.16 −0.127 0.899
Sex 0.53 0.08, 0.99 0.23 76.85 2.297 0.024
SOMATOFORM DISORDERS (Conditional R2 = 0.88, Cook’s distance = 6/15)
Intercept 0.03 −2.69, 2.76 1.39 12.59 0.024 0.981
Time −0.08 −0.2, 0.04 0.06 8.24 −1.236 0.251
Age 0.01 −0.03, 0.05 0.02 12.25 0.438 0.669
Sex −0.11 −1.45, 1.22 0.68 12.36 −0.166 0.871
DISSOCIATIVE DISORDERS (Conditional R2 = 0.81, Cook’s distance = 8/30)
Intercept 1.15 −0.95, 3.24 1.07 26.85 1.074 0.292
Time 0.01 −0.1, 0.12 0.06 16.01 0.240 0.813
Age 0.01 −0.01, 0.04 0.01 27.01 0.967 0.342
Sex −0.56 −1.49, 0.38 0.48 26.54 −1.168 0.253
PERSONALITY DISORDERS (Conditional R2 = 0.70, Cook’s distance = 10/68)
Intercept −0.53 −1.63, 0.57 0.56 68.39 −0.944 0.349
Time −0.03 -0.11, 0.06 0.04 34.75 −0.637 0.528
Age 0.00 -0.02, 0.02 0.01 68.07 0.337 0.737
Sex 0.45 -0.03, 0.92 0.24 66.27 1.848 0.069
β, Standardized beta; diagnostic categories are related to DSM-IV. Cook’s distance, Number of influential/total observations.
influence on the course of function across life domains supports
a recent meta-analysis on anxiety disorders and functional
impairment that found the highest correlation between global
functioning and social anxiety disorder (9). Their observation of
a high correlation of obsessive-compulsive disorder with global
functioning contrasts with our finding of a relatively low effect of
compulsive behavior on functioning. It might be that impaired
functioning is primarily driven by obsessive thoughts and not
compulsive behaviors. This finding needs to be explored further
in future studies because we did not collect data regarding
obsessive thoughts, and the meta-analysis did not discriminate
between distinct symptoms of obsessive-compulsive disorder.
The relatively higher effect sizes we observed for symptoms
of major depression compared to symptoms of anxiety disorders
other than social anxiety is in line with previous evidence from
primary care settings (62). Beyond that, our results suggest
that disability in major depression may be primarily driven by
fatigue, mood, and cognitive impairments and less by sleeping
problems, suicidality or appetite/weight changes. Similarly, we
found that PTSD signs and symptoms (i.e., dissociative reactions,
diminished interest or participation, psychological distress at
exposure to trauma cues, and concentration problems) from
three DSM-5 clusters (B, D, E) showed the highest association
with functional impairment. This might explain inconsistencies
in previous studies that investigated how PTSD clusters, but not
distinct symptoms in the clusters, were associated with impaired
functioning (63–65).
Four of the 10 symptoms that had the highest impact
on functioning in our study (i.e., altered voluntary or
sensory function, disruption of identity, flashbacks, and
depersonalization) related to dissociation. This finding supports
previous evidence showing the profound influence these
symptomsmay have on functioning (27, 66, 67). This relationship
seems particularly relevant given the high scrutiny individuals
with these disorders often encounter in the context of insurance
medicine (68).
The 47 symptom items of the Functional Impairment
Prediction Scale (FIPS), that we developed in this study, mostly
refer to dissociative and depressive symptoms. This does not
seem surprising given the high association we observed between
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FIGURE 2 | Symptom severity during 18 months in outpatients and daycare patients (N = 155) by DSM-IV diagnostic category. The thick red line represents the
mean score across symptoms belonging to this diagnostic category and the associated ribbon the standard deviation. The colored thin lines represent the mean
score across subjects of each symptom belonging to this diagnostic category. Higher scores represent higher severity.
TABLE 4 | Results of linear mixed effect models on the 18-month course of symptom severity of outpatient and daycare patients (N = 155).
Variable β 95% CI SE df t P
AFFECTIVE DISORDERS (Conditional R2 = 0.75, Cook’s distance = 17/78)
Intercept 0.13 −0.45, 0.71 0.30 79.87 0.445 0.657
Time −0.03 −0.1, 0.03 0.03 38.19 −1.028 0.310
Age −0.00 −0.01, 0.01 0.01 76.88 −0.207 0.837
Sex 0.10 −0.15, 0.36 0.13 74.97 0.790 0.432
ANXIETY DISORDERS (Conditional R2 = 0.79, Cook’s distance = 17/80)
Intercept −0.34 −0.98, 0.3 0.33 78.49 −1.052 0.296
Time 0.00 −0.05, 0.06 0.03 30.62 0.165 0.870
Age −0.00 −0.01, 0.01 0.01 76.74 −0.078 0.938
Sex 0.30 0.02, 0.59 0.15 75.67 2.073 0.042
SOMATOFORM DISORDERS (Conditional R2 = 0.70, Cook’s distance = 5/15)
Intercept −0.42 −1.57, 0.72 0.59 14.67 −0.724 0.480
Time −0.06 −0.14, 0.03 0.04 11.70 −1.326 0.210
Age 0.00 −0.01, 0.02 0.01 13.62 0.194 0.849
Sex 0.25 −0.3, 0.81 0.28 14.01 0.888 0.390
DISSOCIATIVE DISORDERS (Conditional R2 = 0.85, Cook’s distance = 7/30)
Intercept 0.56 −0.96, 2.07 0.77 22.66 0.717 0.481
Time 0.01 −0.1, 0.12 0.06 17.65 0.171 0.866
Age 0.00 −0.02, 0.02 0.01 24.35 0.205 0.839
Sex −0.03 −0.7, 0.65 0.34 22.14 −0.078 0.938
β, Standardized beta; diagnostic categories are related to DSM-IV. Cook’s distance, Number of influential/total observations.
functional impairment across life domains andDSM-5 symptoms
related to conversion disorder, dissociative identity disorder
and major depression. Although anxiety symptom items in
the FIPS were weaker associated with WHODAS total scores,
they predicted functioning levels in specific life domains, e.g.,
mobility. We are not aware of any empirically developed
measure that allows prediction of functional impairment from
symptom profiles. Hence, the FIPS may be a valuable tool
in legal assessments. The scale can add an additional level
of empirically derived evidence to the evaluation of working
capacity. Moreover, the combined application of the FIPS
and WHODAS II would allow to compare predicted and
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FIGURE 3 | Association between DSM-5 symptoms and functional impairment across WHODAS II domains during 18 months in outpatients and daycare patients (N
= 155). The order of the symptoms in the graph represent descending magnitudes of the mean standardized parameter estimate across the symptoms related to a
diagnosis, followed by the standardized parameter estimate magnitude of each symptom related to a diagnosis. The DSM-5 symptom criterion for a symptom is given
in parenthesis.
self-reported functional impairment, thereby contributing to the
evaluation of consistency in legal reports. It is noteworthy,
however, that the item selection of the FIPS need be considered
as preliminary and requires validation in separate samples. The
47 questions used in FIPS and their rating scales are presented in
Supplementary Table 14.
The findings from our study have several implications for
legal assessments and rehabilitation.Medical experts in insurance
medicine should be aware that psychiatric disability has a
strong tendency to persist for long periods. Consequently,
they should be realistic when considering the chances for
functional improvement under treatment. Overly optimistic
prognostication may undermine a claimant’s entitlement to
receive occupational disability benefits. Moreover, assessors
should recommend treatment modalities that target signs
and symptoms with strong influences on work functioning.
Concentration problems showed the fourth-highest association
with impaired function among PTSD symptoms in our study.
Therefore, if a traumatized claimant has severe concentration
problems and lower levels of traumatic re-experiencing, a
treatment plan could benefit from inclusion of attention
training (69), even if trauma exposure therapy is considered
the standard treatment in PTSD (70). Finally, our results
enhance the empirical basis for the work capacity evaluation
in legal assessments, which is urgently required in insurance
medicine (71). For instance, arguing an inability to work
due to sleeping problems in the absence of other relevant
symptoms would be difficult to justify given the relatively low
association we observed between sleeping disturbances and
impaired functioning.
A strength of this study is the employment of a detailed
and rigorous diagnostic characterization that included SCID-
I, SCID-II, and SCID-D-R interviews for every participant
enrolled. The use of consecutive recruitment by service providers
allows better generalization of our findings to the population of
general psychiatric patients seeking treatment. Eligible patients
who refused to participate in this study and drop-outs are a
potential threat to the generalizability of the results. However,
study refusers and drop-outs did not differ in sociodemographic
or clinical characteristics from study participants and study
completers, respectively, which makes a recruitment and/or
drop-out bias unlikely. Data presented in this paper have been
retrieved as part of a study on global functioning in dissociative
disorders (27–29), which has influenced the selection of the
scales. The scales used in the study represent major, but not
all, areas of psychopathology in general psychiatric outpatients.
Consequently, we cannot preclude that there are other signs
and symptoms which have contributed to functional impairment
in this study. Given the low sample size in some diagnostic
categories (e.g., substance disorder and somatoform disorder),
some weaker associations with work disability may not have
been detected. A positive association between signs, symptoms
and functional measures does not necessarily imply causal
relationships among them. Ultimately, causality in psychiatric
disability needs to be investigated in experimental studies.
Finally, the Functional Impairment Prediction Scale that was
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TABLE 5 | Items in the Functional Impairment Prediction Scale derived from
clinical and functional impairment measures of outpatients and daycare patients
(N = 155).
Item text Original measure—
item no
Some people sometimes find that they are approached
by people that they do not know who call them by
another name or insist that they have met them before.
DES−6
Some people have the experience of being in a familiar
place but finding it strange and unfamiliar.
DES−16
Some people find that when they are watching
television or a movie they become so absorbed in the
story that they are unaware of other events happening
around them.
DES−17
Some people sometimes find that in certain situations
they are able to do things with amazing ease and
spontaneity that would usually be difficult for them (for
example, sports, work, social situations, etc.).
DES−23
While watching TV, you find that you are thinking about
something else.
MID−1
Feeling as if your body (or certain parts of it) are unreal. MID−3
Having trance-like episodes where you stare off into
space and lose awareness of what is going on around
you.
MID−16
Thoughts being imposed on you or imposed on your
mind.
MID−20
Being unable to remember your name, or age, or
address.
MID−56
Being paralyzed or unable to move (for no known
medical reason).
MID−60
Finding yourself lying in bed (on the sofa, etc.) with no
memory of how you got there.
MID−64
Having difficulty walking (for no known medical reason). MID−82
Hearing a lot of noise or yelling in your head. MID−97
Re-experiencing body sensations from a past
traumatic event.
MID−125
Feeling like you are “inside” yourself, watching what
you are doing.
MID−133
Feeling distant or removed from your thoughts and
actions.
MID−135
Reliving a past trauma so vividly that you see it, hear it,
feel it, smell it, etc.
MID−145
Your thoughts and feelings are so changeable that you
don’t understand yourself.
MID−146
Reliving a traumatic event so totally that you think that
a present-day person is actually a person from the
trauma (for example, being home with your partner,
suddenly reliving being raped by your alcoholic uncle,
and actually thinking that your partner is your
uncle—that is, you see your uncle in front of you
instead of seeing your partner).
MID−156
Feeling as if there is something inside you that takes
control of your behavior or speech.
MID−161
Discovering that you have a significant injury (for
example, a cut, or a burn, or many bruises), and
having no memory of how it happened.
MID−170
Suddenly finding yourself somewhere (for example, at
the beach, at work, in a nightclub, in your car, etc.) with
no memory of how you got there.
MID−173
(Continued)
TABLE 5 | Continued
Item text Original measure—
item no
Some thoughts are suddenly “taken away from you.” MID−198
Feeling a struggle inside you about what to think, how
to feel, what you should do.
MID−210
I dislike smells that I usually like. SDQ−9
I cannot see for a while (as if I am blind). SDQ−12
I grow stiff for a while. SDQ−20
I feel sad. BDI−1
I put off making decisions more than I used to. BDI−13
I get tired more easily than I used to. BDI−17
My appetite is not as good as it used to be. BDI−18
I am worried about physical problems like aches,
pains, upset stomach, or constipation.
BDI−20
I am less interested in sex than I used to be. BDI−21
Feeling afraid in open spaces. BSI−8
Thoughts of ending your life. BSI−9
Feeling blocked in getting things done. BSI−15
Feeling blue. BSI−17
Feeling no interest in things. BSI−18
Difficulty making decisions. BSI−27
Feeling afraid to travel on buses, subways, or trains. BSI−28
Trouble getting your breath. BSI−29
Feeling weak in parts of your body. BSI−37
Feeling tense or keyed up. BSI−38
Feeling very self-conscious with others. BSI−42
Never feeling close to another person. BSI−44
Spells of terror or panic. BSI−45
Feeling nervous when you are left alone. BSI−47
DES, Dissociative Experiences Scale; MID, Multidimensional Inventory of Dissociation;
SDQ-20, Somatoform Dissociation Questionnaire; BDI, Beck Depression Inventory; BSI,
Brief Symptom Inventory. The final questionnaire is available in the Supplemental.
Instructions regarding its application can be obtained from the corresponding author.
developed in this study needs to be cross-validated in an
independent sample of psychiatric patients.
Taken together, this study provides novel insights concerning
which signs and symptoms may be associated with functional
impairment in mental disorders. Given the capability for somatic
and mental symptoms associated with social anxiety, depression,
and dissociation to predict future disability, these measures
have strong potential for guiding rehabilitation planning and
prognostic evaluation in insurance medicine. The high temporal
stability of functional impairment also calls for therapeutic
interventions, such as functional training (72), that go beyond
the treatment of psychopathological symptoms. Confirmation
of the validity of the Functional Impairment Prediction Scale
in predicting disability in future studies will foster the scale
as a valuable, empirical-based extension in legal assessments of
working capacity.
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